Pay in 4 interest-free payments of $6.95 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Citations & References Metabolic Pharmaceuticals Ltd Company Press Release (2007) Heffernan M, Summers RJ, Thorburn A, et al
Rachel Frank, who specializes in joint preservation and cartilage restoration
Heterogeneity of release probability, facilitation, and depletion at central synapses
Additional roles include repairing damaged DNA and protecting cells from stress
The study's single-blind design and placebo control add credibility, but the very small sample size means the results should be interpreted cautiously
While its safety profile was consistently favorable, the largest Phase IIb trial failed to show statistical significance for weight loss, and commercial development was halted in 2007.[2] Despite this, interest in AOD-9604 has continued in the compounding pharmacy and integrative medicine space, particularly given its safety data, its lack of IGF-1 stimulation, and emerging research around joint health
US$ 29.94
US$ 23.41
US$ 23.89
US$ 27.36
US$ 27.11
US$ 22.62
US$ 23.61
US$ 25.46
US$ 20.46
US$ 28.10
US$ 21.61
US$ 21.07
US$ 21.89
US$ 25.59
